PDF herunterladen
Facial Plast Surg 2016; 32(05): 532-555
DOI: 10.1055/s-0036-1592340
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Adverse Reactions to Injectable Fillers

Rebecca Fitzgerald
1   University of California Los Angeles, Los Angeles, California
,
Vince Bertucci
2   Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada
,
Jonathan M. Sykes
3   Department of Otolaryngology/Facial Plastic Surgery, University of California Davis Medical Center, Sacramento, California
,
J. Kevin Duplechain
4   Private Practice, Lafayette, Louisiana
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
28. September 2016 (online)

    Lizenzen und Reprints

Abstract

As the use of fillers becomes increasingly more common and the skill level of those injecting is so varied, adverse events can be expected to increase as well. Avoiding complications is always the best measure, and with appropriate training and injection techniques, many complications can be avoided. However, adverse events can occur in the best of hands, and early detection and treatment may eliminate or minimize sequelae. This article is an effort to help in that endeavor.

Keywords

fillers - complications - adverse events - biofilm - intravascular injection - ischemia - necrosis
 

  • References

  • 1 Rohrich RJ, Nguyen AT, Kenkel JM. Lexicon for soft tissue implants. Dermatol Surg 2009; 35 (Suppl. 02) 1605-1611
    CrossrefPubMedGoogle Scholar
  • 2 DeLorenzi C. Complications of injectable fillers, part I. Aesthet Surg J 2013; 33 (4) 561-575
    CrossrefPubMedGoogle Scholar
  • 3 Rzany B, DeLorenzi C. Understanding, avoiding, and managing severe filler complications. Plast Reconstr Surg 2015; 136 (5, Suppl): 196S-203S
    CrossrefPubMedGoogle Scholar
  • 4 American Society of Plastic Surgeons. 2015 Cosmetic Plastic Surgery Statistics: Cosmetic Procedure Trends. Available at: http://www.plasticsurgery.org/Documents/news-resources/statistics/2015-statistics/2015-plastic-surgery-statistics-report.pdf . Accessed April 16, 2016
    PubMedGoogle Scholar
  • 5 DeLorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthet Surg J 2014; 34 (4) 584-600
    CrossrefPubMedGoogle Scholar
  • 6 Vanaman M, Fabi SG, Carruthers J. Complications in the cosmetic dermatology patient: a review and our experience (part 1). Dermatol Surg 2016; 42 (1) 1-11
    CrossrefPubMedGoogle Scholar
  • 7 Ozturk CN, Li Y, Tung R, Parker L, Piliang MP, Zins JE. Complications following injection of soft-tissue fillers. Aesthet Surg J 2013; 33 (6) 862-877
    CrossrefPubMedGoogle Scholar
  • 8 Beleznay K, Carruthers JD, Humphrey S, Jones D. Avoiding and treating blindness from fillers: a review of the world literature. Dermatol Surg 2015; 41 (10) 1097-1117
    CrossrefPubMedGoogle Scholar
  • 9 Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg 2006; 118 (3, Suppl): 92S-107S
    CrossrefPubMedGoogle Scholar
  • 10 Signorini M, Liew S, Sundaram H , et al; Global Aesthetics Consensus Group. Global Aesthetics Consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations. Plast Reconstr Surg 2016; 137 (6) 961e-971e
    Google Scholar
  • 11 Bailey SH, Cohen JL, Kenkel JM. Etiology, prevention, and treatment of dermal filler complications. Aesthet Surg J 2011; 31 (1) 110-121
    CrossrefPubMedGoogle Scholar
  • 12 Hanke CW, Higley HR, Jolivette DM, Swanson NA, Stegman SJ. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol 1991; 25 (2, Pt 1): 319-326
    CrossrefPubMedGoogle Scholar
  • 13 Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002; 28 (6) 491-494
    CrossrefPubMedGoogle Scholar
  • 14 Narins RS, Jewell M, Rubin M, Cohen J, Strobos J. Clinical conference: management of rare events following dermal fillers—focal necrosis and angry red bumps. Dermatol Surg 2006; 32 (3) 426-434
    CrossrefPubMedGoogle Scholar
  • 15 Daines SM, Williams EF. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review. JAMA Facial Plast Surg 2013; 15 (3) 226-231
    CrossrefPubMedGoogle Scholar
  • 16 Alam M, Kakar R, Nodzenski M , et al. Multicenter prospective cohort study of the incidence of adverse events associated with cosmetic dermatologic procedures: lasers, energy devices, and injectable neurotoxins and fillers. JAMA Dermatol 2015; 151 (3) 271-277
    CrossrefPubMedGoogle Scholar
  • 17 Beleznay K, Carruthers JD, Carruthers A, Mummert ME, Humphrey S. Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management. Dermatol Surg 2015; 41 (8) 929-939
    CrossrefPubMedGoogle Scholar
  • 18 Beleznay K, Humphrey S, Carruthers JD, Carruthers A. Vascular compromise from soft tissue augmentation: experience with 12 cases and recommendations for optimal outcomes. J Clin Aesthet Dermatol 2014; 7 (9) 37-43
    PubMedGoogle Scholar
  • 19 Khalifeh MR, Redett RJ. The management of patients on anticoagulants prior to cutaneous surgery: case report of a thromboembolic complication, review of the literature, and evidence-based recommendations. Plast Reconstr Surg 2006; 118 (5) 110e-117e
    CrossrefPubMedGoogle Scholar
  • 20 Glogau RG, Kane MA. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Dermatol Surg 2008; 34 (Suppl. 01) S105-S109
    CrossrefPubMedGoogle Scholar
  • 21 Zeichner JA, Cohen JL. Use of blunt tipped cannulas for soft tissue fillers. J Drugs Dermatol 2012; 11 (1) 70-72
    Google Scholar
  • 22 Lee GSK. Use of AccuVein™ for preventing complications from accidental venipuncture when administering dermal filler injections. J Cosmet Laser Ther 2015; 17 (1) 55-56
    CrossrefPubMedGoogle Scholar
  • 23 Leonhardt JM, Lawrence N, Narins RS. Angioedema acute hypersensitivity reaction to injectable hyaluronic acid. Dermatol Surg 2005; 31 (5) 577-579
    CrossrefPubMedGoogle Scholar
  • 24 Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg 2000; 26 (2) 135-137
    CrossrefPubMedGoogle Scholar
  • 25 Landau M. Hyaluronidase caveats in treating filler complications. Dermatol Surg 2015; 41 (Suppl. 01) S347-S353
    CrossrefPubMedGoogle Scholar
  • 26 Cohen JL, Biesman BS, Dayan SH , et al. Treatment of hyaluronic acid filler-induced impending necrosis with hyaluronidase: consensus recommendations. Aesthet Surg J 2015; 35 (7) 844-849
    CrossrefPubMedGoogle Scholar
  • 27 Jordan DR, Stoica B. Filler migration: a number of mechanisms to consider. Ophthal Plast Reconstr Surg 2015; 31 (4) 257-262
    CrossrefPubMedGoogle Scholar
  • 28 Rossner F, Rossner M, Hartmann V, Erdmann R, Wiest LG, Rzany B. Decrease of reported adverse events to injectable polylactic acid after recommending an increased dilution: 8-year results from the Injectable Filler Safety study. J Cosmet Dermatol 2009; 8 (1) 14-18
    CrossrefPubMedGoogle Scholar
  • 29 Hart DR, Fabi SG, White WM, Fitzgerald R, Goldman MP. Current concepts in the use of PLLA: clinical synergy noted with combined use of microfocused ultrasound and poly-L-lactic acid on the face, neck, and décolletage. Plast Reconstr Surg 2015; 136 (5, Suppl): 180S-187S
    CrossrefPubMedGoogle Scholar
  • 30 Rodriguez JM, Xie YL, Winthrop KL , et al. Mycobacterium chelonae facial infections following injection of dermal filler. Aesthet Surg J 2013; 33 (2) 265-269
    CrossrefPubMedGoogle Scholar
  • 31 Toy BR, Frank PJ. Outbreak of Mycobacterium abscessus infection after soft tissue augmentation. Dermatol Surg 2003; 29 (9) 971-973
    Google Scholar
  • 32 Schnabel D, Esposito DH, Gaines J , et al; RGM Outbreak Investigation Team. Multistate US outbreak of rapidly growing mycobacterial infections associated with medical tourism to the Dominican Republic, 2013-2014. Emerg Infect Dis 2016; 22 (8) 1340-1347
    CrossrefPubMedGoogle Scholar
  • 33 Agarwal A, Maloney RW. Mycobacterium abscessus outbreak after rhytidectomies performed in an outpatient surgery center. Plast Reconstr Surg 2011; 128 (2) 85e-86e
    CrossrefPubMedGoogle Scholar
  • 34 Alijotas-Reig J, Fernández-Figueras MT, Puig L. Late-onset inflammatory adverse reactions related to soft tissue filler injections. Clin Rev Allergy Immunol 2013; 45 (1) 97-108
    CrossrefPubMedGoogle Scholar
  • 35 Ledon JA, Savas JA, Yang S, Franca K, Camacho I, Nouri K. Inflammatory nodules following soft tissue filler use: a review of causative agents, pathology and treatment options. Am J Clin Dermatol 2013; 14 (5) 401-411
    CrossrefPubMedGoogle Scholar
  • 36 Bisschop C, Bruijn MS, Stenekes MW, Diercks GF, Hospers GAP. Foreign body reaction triggered by CTLA-4 blockade 25 years after dermal filler injection, a case report. Br J Dermatol 2016; ; doi:10.1111/bjd.14674. [Epub ahead of print]
    PubMedGoogle Scholar
  • 37 Dammak A, Taillé C, Marinho E, Crestani B, Crickx B, Descamps V. Granulomatous foreign-body reaction with facial dermal fillers after omalizumab treatment for severe persistent allergic asthma: a case report. Br J Dermatol 2012; 166 (6) 1375-1376
    CrossrefPubMedGoogle Scholar
  • 38 Alijotas-Reig J, Miró-Mur F, Planells-Romeu I, Garcia-Aranda N, Garcia-Gimenez V, Vilardell-Tarrés M. Are bacterial growth and/or chemotaxis increased by filler injections? Implications for the pathogenesis and treatment of filler-related granulomas. Dermatology 2010; 221 (4) 356-364
    CrossrefPubMedGoogle Scholar
  • 39 Alijotas-Reig J, Garcia-Gimenez V, Miró-Mur F, Vilardell-Tarrés M. Delayed immune-mediated adverse effects related to polyacrylamide dermal fillers: clinical findings, management, and follow-up. Dermatol Surg 2009; 35 (Suppl. 01) 360-366
    CrossrefPubMedGoogle Scholar
  • 40 Alijotas-Reig J, Garcia-Gimenez V, Miró-Mur F, Vilardell-Tarrés M. Delayed immune-mediated adverse effects of polyalkylimide dermal fillers: clinical findings and long-term follow-up. Arch Dermatol 2008; 144 (5) 637-642
    PubMedGoogle Scholar
  • 41 Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005; 29 (1) 34-48
    CrossrefPubMedGoogle Scholar
  • 42 Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg 2007; 33 (Suppl. 02) S168-S175
    CrossrefPubMedGoogle Scholar
  • 43 Bjarnsholt T, Tolker-Nielsen T, Givskov M, Janssen M, Christensen LH. Detection of bacteria by fluorescence in situ hybridization in culture-negative soft tissue filler lesions. Dermatol Surg 2009; 35 (Suppl. 02) 1620-1624
    CrossrefPubMedGoogle Scholar
  • 44 Christensen LH. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol Surg 2009; 35 (Suppl. 02) 1612-1619
    CrossrefPubMedGoogle Scholar
  • 45 Artzi O, Loizides C, Verner I, Landau M. Resistant and recurrent late reaction to hyaluronic acid-based gel. Dermatol Surg 2016; 42 (1) 31-37
    CrossrefPubMedGoogle Scholar
  • 46 Kadouch JA, Kadouch DJ, Fortuin S, van Rozelaar L, Karim RB, Hoekzema R. Delayed-onset complications of facial soft tissue augmentation with permanent fillers in 85 patients. Dermatol Surg 2013; 39 (10) 1474-1485
    PubMedGoogle Scholar
  • 47 Alhede M, Bjarnsholt T. Are biofilms responsible for the adverse effects experienced following soft-tissue fillers?. Future Microbiol 2014; 9 (8) 931-933
    CrossrefPubMedGoogle Scholar
  • 48 Nygart JF, Nygart VA, Borggren M, Tvede M. Effect of prophylactic antibiotics on polyacrylamide gel safety in facial augmentation. J Drugs Dermatol 2014; 13 (5) 571-573
    PubMedGoogle Scholar
  • 49 Deva AK, Adams Jr WP, Vickery K. The role of bacterial biofilms in device-associated infection. Plast Reconstr Surg 2013; 132 (5) 1319-1328
    CrossrefPubMedGoogle Scholar
  • 50 Constantine RS, Constantine FC, Rohrich RJ. The ever-changing role of biofilms in plastic surgery. Plast Reconstr Surg 2014; 133 (6) 865e-872e
    CrossrefPubMedGoogle Scholar
  • 51 Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284 (5418) 1318-1322
    CrossrefPubMedGoogle Scholar
  • 52 Monheit GD, Rohrich RJ. The nature of long-term fillers and the risk of complications. Dermatol Surg 2009; 35 (Suppl. 02) 1598-1604
    CrossrefPubMedGoogle Scholar
  • 53 Attila C, Ueda A, Wood TK. 5-Fluorouracil reduces biofilm formation in Escherichia coli K-12 through global regulator AriR as an antivirulence compound. Appl Microbiol Biotechnol 2009; 82 (3) 525-533
    CrossrefPubMedGoogle Scholar
  • 54 Cassuto D, Marangoni O, De Santis G, Christensen L. Advanced laser techniques for filler-induced complications. Dermatol Surg 2009; 35 (Suppl. 02) 1689-1695
    Google Scholar
  • 55 Cassuto D, Pignatti M, Pacchioni L, Boscaini G, Spaggiari A, De Santis G. Management of complications caused by permanent fillers in the face: a treatment algorithm. Plast Reconstr Surg 2016; 138 (2) 215e-227e
    CrossrefPubMedGoogle Scholar
  • 56 Beer K, Avelar R. Relationship between delayed reactions to dermal fillers and biofilms: facts and considerations. Dermatol Surg 2014; 40 (11) 1175-1179
    CrossrefPubMedGoogle Scholar
  • 57 Jayaraman A, Wood TK. Bacterial quorum sensing: signals, circuits, and implications for biofilms and disease. Annu Rev Biomed Eng 2008; 10: 145-167
    CrossrefPubMedGoogle Scholar
  • 58 Ramzi AA, Kassim M, George JV, Amin A. Dental procedures: is it a risk factor for injectable dermal fillers?. J Maxillofac Oral Surg 2015; 14 (Suppl. 01) 158-160
    CrossrefPubMedGoogle Scholar
  • 59 Marusza W, Mlynarczyk G, Olszanski R , et al. Probable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16. Int J Nanomedicine 2012; 7: 1441-1447
    PubMedGoogle Scholar
  • 60 Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR ; Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Am J Infect Control 1999; 27 (2) 97-132 , quiz 133–134, discussion 96
    CrossrefPubMedGoogle Scholar
  • 61 Darouiche RO, Wall Jr MJ, Itani KM , et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010; 362 (1) 18-26
    CrossrefPubMedGoogle Scholar
  • 62 Center for Health and Safety Communications. Unintentional Injection of Soft Tissue Filler into Blood Vessels in the Face: FDA Safety Communication. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm448255.htm . Accessed May 28, 2015
    PubMedGoogle Scholar
  • 63 Lazzeri D, Agostini T, Figus M, Nardi M, Pantaloni M, Lazzeri S. Blindness following cosmetic injections of the face. Plast Reconstr Surg 2012; 129 (4) 995-1012
    CrossrefPubMedGoogle Scholar
  • 64 Park KH, Kim YK, Woo SJ , et al; Korean Retina Society. Iatrogenic occlusion of the ophthalmic artery after cosmetic facial filler injections: a national survey by the Korean Retina Society. JAMA Ophthalmol 2014; 132 (6) 714-723
    CrossrefPubMedGoogle Scholar
  • 65 Larrabee WF, Makielski KH, Henderson JL. Surgical Anatomy of the Face. Philadelphia, PA: Lippincott Williams & Wilkins; 2004
    Google Scholar
  • 66 Carruthers JDA, Fagien S, Rohrich RJ, Weinkle S, Carruthers A. Blindness caused by cosmetic filler injection: a review of cause and therapy. Plast Reconstr Surg 2014; 134 (6) 1197-1201
    CrossrefPubMedGoogle Scholar
  • 67 Chen W, Wu L, Jian XL , et al. Retinal branch artery embolization following hyaluronic acid injection: a case report. Aesthet Surg J 2016; 36 (7) NP219-NP224
    CrossrefPubMedGoogle Scholar
  • 68 Kim Y-K, Jung C, Woo SJ, Park KH. Cerebral angiographic findings of cosmetic facial filler-related ophthalmic and retinal artery occlusion. J Korean Med Sci 2015; 30 (12) 1847-1855
    CrossrefPubMedGoogle Scholar
  • 69 Pessa J, Rohrich R. Facial Topography: Clinical Anatomy of the Face. St. Louis, MO: Quality Medical Publishing; 2012
    Google Scholar
  • 70 Carey W, Weinkle S. Retraction of the plunger on a syringe of hyaluronic acid before injection: are we safe?. Dermatol Surg 2015; 41 (Suppl. 01) S340-S346
    CrossrefPubMedGoogle Scholar
  • 71 Sun Z-S, Zhu GZ, Wang HB , et al. Clinical outcomes of impending nasal skin necrosis related to nose and nasolabial fold augmentation with hyaluronic acid fillers. Plast Reconstr Surg 2015; 136 (4) 434e-441e
    CrossrefPubMedGoogle Scholar
  • 72 Hwang CJ, Morgan PV, Pimentel A, Sayre JW, Goldberg RA, Duckwiler G. Rethinking the role of nitroglycerin ointment in ischemic vascular filler complications: an animal model with ICG imaging. Ophthal Plast Reconstr Surg 2016; 32 (2) 118-122
    CrossrefPubMedGoogle Scholar
  • 73 Jones D, Tezel A, Borrell M. In vitro resistance to degradation of hyaluronic acid dermal fillers by ovine testicular hyaluronidase. Dermatol Surg 2010; 36 (1) 804-809
    CrossrefPubMedGoogle Scholar
  • 74 Kulikovsky M, Gil T, Mettanes I, Karmeli R, Har-Shai Y. Hyperbaric oxygen therapy for non-healing wounds. Isr Med Assoc J 2009; 11 (8) 480-485
    PubMedGoogle Scholar
  • 75 Darling MD, Peterson JD, Fabi SG. Impending necrosis after injection of hyaluronic acid and calcium hydroxylapatite fillers: report of 2 cases treated with hyperbaric oxygen therapy. Dermatol Surg 2014; 40 (9) 1049-1052
    CrossrefPubMedGoogle Scholar